With April well underway, we are proud to announce that the Health of Women (HOW) Study (www.healthofwomenstudy.org) has reached more than 40,000 participants! The Dr. Susan Love Research Foundation's newest research initiative HOW is a unique, long-term, online study of women and men that seeks to understand what causes breast cancer and what factors contribute to long-term survivorship.
You are here
Dr. Susan Love
Yesterday we were greeted with an amazing study that demonstrated one of the problems in current medical research. In sum this was the study's finding: We are NOT mice!
When I started out as a breast surgeon in the early 1980's, most women diagnosed with breast cancer were told they needed to have a modified radical mastectomy removal of the breast and all of the lymph nodes in the armpit. Many others were still being treated with a radical mastectomy removal of the breast and lymph nodes and the pectoral (chest) muscle. Why? Surgeons strongly believed that the more they removed the lower the chance of having the breast cancer come back.
My name is Ashley and in January 2012 I was diagnosed with breast cancer at 28 years old. I had no major risk factors and cancer was the last thing I thought I would be dealing with at my age. In fact, I didn't even know that breast cancer could happen to women in their twenties!
Cancer patients have been telling their doctors about the foggy thinking and forgetfulness that are often referred to as 'chemobrain' for years. Initially, many doctors didn't take these complaints seriously. But as more attention began to be paid to cancer survivors' quality of life, cognitive functioning began to be seen as a topic that needs study.
Tamoxifen has been used for so long to treat breast cancer that most of us assumed we knew everything that we needed to know about it including how long women should take it. But yesterday at the San Antonio Breast Cancer Symposium we all learned something new when researchers presented results from the ATLAS trial (Adjuvant Tamoxifen: Longer Against Shorter).
Lots of medical meetings are held at this time of year, which means lots of media coverage of new breast cancer research. Whenever you hear about a new study, keep in mind that any results that are presented but not published have not passed the critical peer review process and are considered preliminary.